Solid Biosciences Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Solid Biosciences Inc. (SLDB), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are SLDB insiders buying or selling?
In the last 12 months, Solid Biosciences Inc. insiders reported 0 open-market purchases ($0) and 28 sales ($2.7M) — net selling of $2.7M. Since January 2018, Trabud has recorded 99 Form 4 filings for SLDB: 13 buys ($128.1M) and 86 sells ($14.2M).
Source: SEC EDGAR Form 4
Key Statistics (January 2018 – Feb 19, 2026)
Total Form 4 filings
99
SEC EDGAR
Insider filers
24
Insider buys (13)
$128.1M
Insider sells (86)
$14.2M
Insider sentiment
Net buyingNet insider flow of $114.0M in net buying since January 2018, and $2.7M in net selling over the last 12 months.
Recent SLDB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Alexander Cumbo | President and CEO | Sale | 16.6K | $5.82 | $96.9K | SEC ↗ |
| Feb 19, 2026 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 4.1K | $5.82 | $24.1K | SEC ↗ |
| Feb 19, 2026 | Ilan Ganot | Director | Sale | 2.7K | $5.82 | $15.5K | SEC ↗ |
| Feb 19, 2026 | Paul Herzich | Chief Technology Officer | Sale | 3.6K | $5.82 | $21.1K | SEC ↗ |
| Feb 19, 2026 | David T Howton | Chief Operating Officer | Sale | 7.5K | $5.82 | $43.5K | SEC ↗ |
| Feb 19, 2026 | Kevin Tan | CFO & Treasurer | Sale | 5.4K | $5.82 | $31.5K | SEC ↗ |
| Feb 6, 2026 | David T Howton | Chief Operating Officer | Sale | 18.9K | $6.44 | $121.7K | SEC ↗ |
| Feb 6, 2026 | Alexander Cumbo | President and CEO | Sale | 48.9K | $6.44 | $315.1K | SEC ↗ |
| Feb 6, 2026 | Ilan Ganot | Director | Sale | 7.2K | $6.44 | $46.4K | SEC ↗ |
| Feb 6, 2026 | Kevin Tan | CFO & Treasurer | Sale | 14.8K | $6.44 | $95.2K | SEC ↗ |
| Feb 6, 2026 | Gabriel Brooks | Chief Medical Officer | Sale | 12.6K | $6.44 | $81.3K | SEC ↗ |
| Feb 6, 2026 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 12.3K | $6.44 | $79.5K | SEC ↗ |
| Feb 6, 2026 | Paul Herzich | Chief Technology Officer | Sale | 10.9K | $6.44 | $70.2K | SEC ↗ |
| Feb 3, 2026 | Kevin Tan | CFO & Treasurer | Sale | 26.8K | $6.44 | $172.7K | SEC ↗ |
| Feb 3, 2026 | Alexander Cumbo | President and CEO | Sale | 80.3K | $6.44 | $516.6K | SEC ↗ |
| Feb 3, 2026 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 26.5K | $6.44 | $170.8K | SEC ↗ |
| Feb 3, 2026 | Gabriel Brooks | Chief Medical Officer | Sale | 28.3K | $6.44 | $182.4K | SEC ↗ |
| Feb 3, 2026 | David T Howton | Chief Operating Officer | Sale | 37.8K | $6.44 | $243.1K | SEC ↗ |
| Feb 3, 2026 | Paul Herzich | Chief Technology Officer | Sale | 26.3K | $6.44 | $169.0K | SEC ↗ |
| Jan 30, 2026 | Ilan Ganot | Director | Sale | 191 | $6.59 | $1.3K | SEC ↗ |
| Jan 13, 2026 | Kevin Tan | CFO & Treasurer | Sale | 5.7K | $5.27 | $30.1K | SEC ↗ |
| Jan 6, 2026 | Ilan Ganot | Director | Sale | 1.1K | $5.43 | $5.7K | SEC ↗ |
| Dec 4, 2025 | David T Howton | Chief Operating Officer | Sale | 4.9K | $5.11 | $25.2K | SEC ↗ |
| Dec 4, 2025 | Alexander Cumbo | President and CEO | Sale | 10.8K | $5.11 | $55.2K | SEC ↗ |
| Dec 4, 2025 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 4.5K | $5.11 | $22.9K | SEC ↗ |
Showing the 25 most recent of 99 Form 4 filings for Solid Biosciences Inc..
Most active SLDB insiders
- Ilan Ganot19 filings
- Alexander Cumbo7 filings
- David T Howton7 filings
- Jessie Hanrahan7 filings
- Kevin Tan7 filings
Ask anything about SLDB insider activity
Use Trabud's AI agent to query Solid Biosciences Inc.'s Form 4 history in plain English — "Show me SLDB CEO purchases this year" or compare it against any other ticker.
Open the AI agentSLDB insider trading FAQ
Are Solid Biosciences Inc. insiders buying or selling?
In the last 12 months, Solid Biosciences Inc. insiders reported 0 open-market purchases ($0) and 28 sales ($2.7M) — net selling of $2.7M. Since January 2018, Trabud has recorded 99 Form 4 filings for SLDB: 13 buys ($128.1M) and 86 sells ($14.2M). Over the full record that is net buying of $114.0M.
How many insiders trade SLDB stock?
24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Solid Biosciences Inc.. The most recent filing was accepted on Feb 19, 2026.
Where does Trabud get SLDB insider trading data?
All SLDB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.